$XBI $138.7 +1.0%
Pipeline Updates
$LXRX +18.7% Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions. source
$MDGL -0.3% Madrigal Pharmaceuticals Announces Presentation of Positive Clinical Data of Resmetirom from Open-Label Portion of Ongoing Phase 3 Clinical Trial MAESTRO-NAFLD-1 at The International Liver Congress™ 2021. source
$AUPH -1.0% Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA) source
$PIRS -8.5% Pieris Pharmaceuticals Announces Inhaled CTGF Inhibitor PRS-220 for Idiopathic Pulmonary Fibrosis and 17 Million Dollar Grant From Bavarian Government To Accelerate Program Development for Post-COVID-19 Pulmonary Fibrosis source
$DYN 0.4% Dyne Therapeutics Presents Preclinical Data from its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress source
$ARWR +0.9% Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress source
$JAZZ +1.3% Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution source
$IMAB -4.0% I-Mab Announces China NMPA Approval for Phase 1b Trial of Felzartamab in Systemic Lupus Erythematosus source
$VERU -0.4% Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111) in Metastatic Castration Resistant and Androgen Receptor Targeting Agent Resistant Prostate Cancer source
$VIR -8.2% Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021 source
$FGEN -4.9% Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease source
Financial Updates
$OSMT +33.1% Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC. source
$RVVTF +1.2% Revive Therapeutics Approved to Trade on the OTCQB Market. source
$GNFT +1.1% GENFIT obtains non-dilutive financing of €11 million in the form of a State Guaranteed Loan source
$AVXL -0.8% Anavex Life Sciences Announces Closing of $50 Million Registered Direct Offering source
$TBPH -8.8% Theravance Biopharma, Inc. Announces Proposed Public Offering of Ordinary Shares source
Posted by FS
Comments